UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Implementation of Risk-reducing Strategies for Breast Cancer is Long Overdue

Cancer prevention research (Philadelphia, Pa.), 2021-01, Vol.14 (1), p.1-4

Vogel, Victor G

2021

Volltextzugriff (PDF)

Breast cancer risk reduction: Notable achievements and remaining challenges

The breast journal, 2020-01, Vol.26 (1), p.86-91

Vogel, Victor G.

2020

Volltextzugriff (PDF)

The Burdens and Uncertainties of Doing What One Should Do

Cancer prevention research (Philadelphia, Pa.), 2017-08, Vol.10 (8), p.431-433

Vogel, Victor G

2017

Volltextzugriff (PDF)

“I have a doctor that handles all the other stuff.” Perceptions of older adults with cancer about discussing aging-related conditions with their oncologists

Journal of geriatric oncology, 2024-09, p.102065, Article 102065

2024

Volltextzugriff (PDF)

PA- and NP-led Ommaya clinics to manage leptomeningeal carcinomatosis

JAAPA (Montvale, N.J.), 2021-12, Vol.34 (12), p.35-41

2021

Volltextzugriff (PDF)

The Relationship Between Tamoxifen, Estrogen, and Depressive Symptoms

The breast journal, 1999-11, Vol.5 (6), p.375-382

1999

Volltextzugriff (PDF)

Tamoxifen, raloxifene and tibolone decrease risk of invasive breast cancer in healthy women but increase risk of thromboembolism (tamoxifen, raloxifene), endometrial cancer (tamoxifen) or stroke (tibolone)

Evidence-based medicine (English ed.), 2010-08, Vol.15 (4), p.122-122

Vogel, Victor G

2010

Volltextzugriff (PDF)

Rates of adherence to bone health guidelines for women with breast cancer treated with anti-estrogen therapy

Journal of clinical oncology, 2020-05, Vol.38 (15_suppl), p.7051-7051

2020

Volltextzugriff (PDF)

Update on raloxifene: role in reducing the risk of invasive breast cancer in postmenopausal women

Breast cancer targets and therapy, 2011-10, Vol.3 (default), p.127-137

Vogel, Victor G

2011

Volltextzugriff (PDF)

Prospective screening study of 0.5 Tesla dedicated magnetic resonance imaging for the detection of breast cancer in young, high-risk women

BMC women's health, 2006-06, Vol.6 (1), p.10-10, Article 10

2006

Volltextzugriff (PDF)

Raloxifene: a selective estrogen receptor modulator for reducing the risk of invasive breast cancer in postmenopausal women

Women's health (London, England), 2007-03, Vol.3 (2), p.139-153

Vogel, Victor G

2007

Volltextzugriff (PDF)

Exploring decisional control preferences in older patients with cancer and their caregivers

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.12042-12042

2023

Volltextzugriff (PDF)

Pathological complete response rate (pCR) in thirty-three women with triple-negative breast cancer (TNBC) treated with a neoadjuvant carboplatin-based regimen

Journal of clinical oncology, 2019-05, Vol.37 (15_suppl), p.e12099-e12099

2019

Volltextzugriff (PDF)

Update on Breast Cancer Risk Reduction Therapy

Current breast cancer reports, 2016-09, Vol.8 (3), p.175-182

Vogel, Victor G.

2016

Volltextzugriff (PDF)

Abstract FO02-01: Lessons learned from 20 years of chemoprevention research

Cancer prevention research (Philadelphia, Pa.), 2012-11, Vol.5 (11_Supplement), p.FO02-01-FO02-01

Vogel, Victor G.

2012

Volltextzugriff (PDF)

Longer Therapy, Iatrogenic Amenorrhea, and Survival in Early Breast Cancer

Obstetrical & gynecological survey, 2010-11, Vol.65 (11), p.710-712

2010

Volltextzugriff (PDF)

Response to letter of Meinert et al

Clinical trials (London, England), 2008-10, Vol.5 (5), p.558-558

2008

Volltextzugriff (PDF)

A pragmatic cluster-randomized trial of a standing physician order entry intervention for colony stimulating factor use among patients at intermediate risk for febrile neutropenia (SWOG S1415CD)

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.1518-1518

2022

Volltextzugriff (PDF)

A pragmatic cluster-randomized trial of a computerized clinical decision support system to improve colony stimulating factor prescribing for patients with cancer receiving myelosuppressive chemotherapy (SWOG S1415CD)

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.1525-1525

2022

Volltextzugriff (PDF)

Using machine learning to identify older adults at high risk for hospitalization and mortality via the Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE)

Journal of clinical oncology, 2020-10, Vol.38 (29_suppl), p.169-169

2020

Volltextzugriff (PDF)

Breast cancer chemoprevention in primary care: Assessing readiness for change

Journal of clinical oncology, 2016-05, Vol.34 (15_suppl), p.1547-1547

2016

Volltextzugriff (PDF)

Optimal Management of Primary Breast Cancer

The breast journal, 1999-03, Vol.5 (2), p.81-93

1999

Volltextzugriff (PDF)

Patient-Reported Symptoms and Quality of Life During Treatment With Tamoxifen or Raloxifene for Breast Cancer Prevention. The NSABP Study of Tamoxifen and Raloxifene (STAR) P-2 Trial

Obstetrical & gynecological survey, 2006-10, Vol.61 (10), p.651-653

2006

Volltextzugriff (PDF)

Update on Estrogen Receptor–Positive Breast Cancer Risk Reduction

Current breast cancer reports, 2011-09, Vol.3 (3), p.156-164

Vogel, Victor G.

2011

Volltextzugriff (PDF)

1 – 25 von 72

Suche als RSS-Feed

Aktive Filter

KollektionMEDLINE

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(63)
Mit Volltextzugriff
(57)

Publikationsform

Sprache

Englisch
(71)
Deutsch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(18)
Life Sciences & Biomedicine
(16)
Oncology
(9)
Breast Cancer
(8)
Biological And Medical Sciences
(7)
Medical Sciences
(7)
Tumors
(6)
Health Risk Assessment
(4)
Raloxifene
(4)
Selective Estrogen Receptor Modulators
(4)
Tamoxifen
(4)
Chemoprevention
(3)
Gynecology. Andrology. Obstetrics
(3)
Hormone Replacement Therapy
(3)
Mammary Gland Diseases
(3)
Medical Research
(3)
Obstetrics & Gynecology
(3)
Oncologists
(3)
Pharmacology. Drug Treatments
(3)
Prevention
(3)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Implementation of Risk-reducing Strategies for Breast Cancer is Long Overdue

Breast cancer risk reduction: Notable achievements and remaining challenges

The Burdens and Uncertainties of Doing What One Should Do

“I have a doctor that handles all the other stuff.” Perceptions of older adults with cancer about discussing aging-related conditions with their oncologists

Correction to: Early cancer diagnoses through BRCA1/2 screening of unselected adult biobank participants

PA- and NP-led Ommaya clinics to manage leptomeningeal carcinomatosis

The Relationship Between Tamoxifen, Estrogen, and Depressive Symptoms

Tamoxifen, raloxifene and tibolone decrease risk of invasive breast cancer in healthy women but increase risk of thromboembolism (tamoxifen, raloxifene), endometrial cancer (tamoxifen) or stroke (tibolone)

Rates of adherence to bone health guidelines for women with breast cancer treated with anti-estrogen therapy

Update on raloxifene: role in reducing the risk of invasive breast cancer in postmenopausal women

Prospective screening study of 0.5 Tesla dedicated magnetic resonance imaging for the detection of breast cancer in young, high-risk women

Raloxifene: a selective estrogen receptor modulator for reducing the risk of invasive breast cancer in postmenopausal women

Exploring decisional control preferences in older patients with cancer and their caregivers

Pathological complete response rate (pCR) in thirty-three women with triple-negative breast cancer (TNBC) treated with a neoadjuvant carboplatin-based regimen

Update on Breast Cancer Risk Reduction Therapy

Abstract FO02-01: Lessons learned from 20 years of chemoprevention research

Longer Therapy, Iatrogenic Amenorrhea, and Survival in Early Breast Cancer

Response to letter of Meinert et al

A pragmatic cluster-randomized trial of a standing physician order entry intervention for colony stimulating factor use among patients at intermediate risk for febrile neutropenia (SWOG S1415CD)

A pragmatic cluster-randomized trial of a computerized clinical decision support system to improve colony stimulating factor prescribing for patients with cancer receiving myelosuppressive chemotherapy (SWOG S1415CD)

Using machine learning to identify older adults at high risk for hospitalization and mortality via the Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE)

Breast cancer chemoprevention in primary care: Assessing readiness for change

Optimal Management of Primary Breast Cancer

Patient-Reported Symptoms and Quality of Life During Treatment With Tamoxifen or Raloxifene for Breast Cancer Prevention. The NSABP Study of Tamoxifen and Raloxifene (STAR) P-2 Trial

Update on Estrogen Receptor–Positive Breast Cancer Risk Reduction

Aktive Filter

Suchergebnisse filtern